[
  {
    "ts": null,
    "headline": "Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors",
    "summary": "Glancy Prongay & Murray LLP , a leading national shareholder rights law firm, continues its investigation on behalf of Regeneron Pharmaceuticals, Inc. investors concerning the Company’s possible...",
    "url": "https://finnhub.io/api/news?id=fbe383161227acbebc6c9b8a75c5faa3759b6083a8414e1b70637c8557b86013",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732723264,
      "headline": "Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors",
      "id": 131672851,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "Glancy Prongay & Murray LLP , a leading national shareholder rights law firm, continues its investigation on behalf of Regeneron Pharmaceuticals, Inc. investors concerning the Company’s possible...",
      "url": "https://finnhub.io/api/news?id=fbe383161227acbebc6c9b8a75c5faa3759b6083a8414e1b70637c8557b86013"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Insiders Sold US$38m Of Shares Suggesting Hesitancy",
    "summary": "In the last year, many Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN ) insiders sold a substantial stake in the company...",
    "url": "https://finnhub.io/api/news?id=d1dc484daf561a9e616972049f66a34d92f63c3e220cb058565689b1d514e31c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732716010,
      "headline": "Regeneron Pharmaceuticals Insiders Sold US$38m Of Shares Suggesting Hesitancy",
      "id": 131667597,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "In the last year, many Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN ) insiders sold a substantial stake in the company...",
      "url": "https://finnhub.io/api/news?id=d1dc484daf561a9e616972049f66a34d92f63c3e220cb058565689b1d514e31c"
    }
  }
]